燃石醫學 BNR 深 滬
等待開盤 01-28 09:30:00 美东时间
35.75
+0.360
+1.02%
華盛通- 最 高36.26
- 今 開36.26
- 成交量 1.04万股
- 最 低 35.00
- 昨 收 35.39
- 總市值 3.85亿
- 52周最高 41.72
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 2.18
- 委 比 60.00%
- 總股本 1076.66万
- 歷史最高 397.50
- 量 比 0.29
- 振 幅 3.56%
- 歷史最低 2.18
- 每 手 1
- 風險率 7.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多“聚能创新 共话湾区”2026生物医药上市公司春季路演 解码创新药投资新逻辑
2026年1月22日-23日，由乐赢投资、国投证券国际、投研会联合主办，智信财经、东莞市私募基金业协会、建国路128号联袂承办，以“聚能创新 共话湾区”为主题举...
01-26 16:22
Burning Rock Biotech Breast Cancer NGS CDx Kit Enters CMDE Priority Review Channel
Burning Rock Biotech Breast Cancer NGS CDx Kit Enters CMDE Priority Review Channel Burning Rock Biotech Ltd. announced that its self-developed "OncoScreen® BCMatch Tissue Kit," a breast cancer NGS companion diagnostic (CDx) kit, has entered the Priority Review Channel of the Center for Medical Devic
01-26 15:13
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers IO Biotech (NASDAQ:IOBT) stock increased by 76.7% to $0.37 during Thur...
01-23 01:05
美股异动 | 燃石医学(BNR.US)涨逾10% 开发OncoCompass技术赋能肿瘤精准诊疗
继昨日股价大涨18.49%之后，周四，燃石医学(BNR.US)再度涨逾10%，报31.483美元。
01-15 23:19
广州黄埔：打造“生物医药与健康产业高地”
中新网广州1月7日电 (张璐 孙旭东)“国产创新药如今在全球医药领域的应用日益广泛，品牌影响力与信任度正快速累积。”百奥泰生物制药股份有限公司(简称“百奥泰”...
01-07 16:42
锚定新目标，黄埔生物医药产业开局即冲刺
岁末年初，正是生物医药企业冲刺的关键期。在生物医药产业集聚的广州国际生物岛（以下简称生物岛），时下更是一片忙碌景象，创新药企业订单量不断刷新，药械企业等待着新一...
01-06 23:24
Burning Rock Announces Founder’s Purchase of Its ADSs
Burning Rock Biotech Limited founder and CEO Mr. Yusheng Han has purchased $811,721.28 worth of the company's ADSs, demonstrating his confidence in its business and future prospects. Mr. Han may continue to acquire ADSs based on market conditions and regulatory policies. The company specializes in applying next-generation sequencing technology in precision oncology, focusing on late-stage cancer treatment selection and early cancer detection.
01-05 06:16
中概股周涨跌榜 | 百度涨超20%，有道涨超18%
盟军集团涨83.9%；Yimutian Inc. Unsponsored ADR Class A涨29.0%；百度涨20.4%
01-04 10:07
Burning Rock Announces Results of 2025 Annual General Meeting
Burning Rock Biotech Limited (NASDAQ: BNR) announced that all shareholder resolutions at its 2025 annual general meeting were passed. Key resolutions include: (1) appointment of Ernst & Young Hua Ming LLP as auditor for FY2025; (2) re-election of Feng Deng and Licen Lisa Xu as directors; and (3) authorization for directors to take necessary actions. Burning Rock focuses on applying next generation sequencing (NGS) technology in precision oncology...
2025-12-23 04:04
